Longitudinal trajectories of plasma polyunsaturated fatty acids and associations with psychosis spectrum outcomes in early adulthood
Background: Evidence supports associations between polyunsaturated fatty acids such as docosahexaenoic acid (DHA) and psychosis. However, polyunsaturated fatty acid trajectories in the general population have not been characterized, and associations with psychosis spectrum outcomes in early adulthood are unknown.
Methods: Plasma omega-6 to omega-3 ratio and DHA (expressed as percentage of total fatty acids) were measured by nuclear magnetic spectroscopy at 7, 15, 17, and 24 years of age in participants of ALSPAC (Avon Longitudinal Study of Parents and Children). Curvilinear growth mixture modeling evaluated body mass index-adjusted trajectories of both measures. Outcomes were assessed at 24 years. Psychotic experiences (PEs), at-risk mental state status, psychotic disorder, and number of PEs were assessed using the Psychosis-Like Symptoms interview (n = 3635; 2247 [61.8%] female). Negative symptoms score was measured using the Community Assessment of Psychic Experiences (n = 3484; 2161 [62.0%] female). Associations were adjusted for sex, ethnicity, parental social class, and cumulative smoking and alcohol use.
Results: Relative to stable average, the persistently high omega-6 to omega-3 ratio trajectory was associated with increased odds of PEs and psychotic disorder, but attenuated on adjustment for covariates (PEs adjusted odds ratio [aOR] = 1.63, 95% CI = 0.92-2.89; psychotic disorder aOR = 1.69, 95% CI = 0.71-4.07). This was also the case for persistently low DHA (PEs aOR = 1.42, 95% CI = 0.84-2.37; psychotic disorder aOR = 1.14, 95% CI = 0.49-2.67). Following adjustment, persistently high omega-6 to omega-3 ratio was associated with increased number of PEs (β = 0.41, 95% CI = 0.05-0.78) and negative symptoms score (β = 0.43, 95% CI = 0.14-0.72), as was persistently low DHA (number of PEs β = 0.45, 95% CI = 0.14-0.76; negative symptoms β = 0.35, 95% CI = 0.12-0.58).
Conclusions: Optimization of polyunsaturated fatty acid status during development warrants further investigation in relation to psychotic symptoms in early adulthood.
Funding
Queen’s University Belfast and the Belfast Health and Social Care Trust Clinical Lectureship
University of Cambridge and Cambridgeshire
Peterborough National Health Service Foundation Trust Clinical Lectureship
Health Research Board Grant No. HRB ILP-PHR-2019-009 and Grant No. HRB/HRA/PHR/2015-1293
European Research Council Consolidator Award (iHEAR Grant No. 724809)
Wellcome Trust Innovations Award (Grant No. 220438Z/20/Z)
National Institute of Health and Care Research Biomedical Research Centre at University Hospitals Bristol
Weston National Health Service Foundation Trust
University of Bristol
Science Foundation Ireland (Grant No. 21/RC/10294_P2)
European Regional Development Fund
FutureNeuro industry partners
Medical Research Council (Grant No MC_UU_12013/1)
The Avon Longitudinal Study of Parents and Children (ALSPAC): A multi- generation, longitudinal resource focusing on life course health and well- being.
Wellcome Trust
Find out more...Pathways to psychosis: Investigating environmental, cognitive and genetic mechanisms underlying development of psychotic experiences in young adults
Medical Research Council
Find out more...History
Comments
The original article is available at https://www.sciencedirect.com/Published Citation
Mongan D. et al. Longitudinal trajectories of plasma polyunsaturated fatty acids and associations with psychosis spectrum outcomes in early adulthood. Biol Psychiatry. 2024;96(10):772-781Publication Date
15 April 2024External DOI
PubMed ID
38631425Department/Unit
- Beaumont Hospital
- FutureNeuro Centre
- Psychiatry
Publisher
ElsevierVersion
- Published Version (Version of Record)